|
| Development of a preclinical humanized mouse model to evaluate acute toxicity of an influenza vaccine |
|
https://doi.org/10.18632/oncotarget.25399
Eita Sasaki, Haruka Momose, Yuki Hiradate, Keiko Furuhata, Takuo Mizukami, and Isao Hamaguchi
|
| 25751-25763 |
|
| Preclinical validation of B cell maturation antigen BCMA as a target for T cell immunotherapy of multiple myeloma |
|
https://doi.org/10.18632/oncotarget.25359
De-Xiu Bu, Reshma Singh, Eugene E. Choi, Marco Ruella, Selene Nunez-Cruz, Keith G. Mansfield, Paul Bennett, Nathanial Barton, Qilong Wu, Jiquan Zhang, Yongqiang Wang, Lai Wei, Shawn Cogan, Tucker Ezell, Shree Joshi, Kellie J. Latimer, Brian Granda, William R. Tschantz, Regina M. Young, Heather A. Huet, Celeste J. Richardson, and Michael C. Milone
|
| 25764-25780 |
|
| Suppression of focal adhesion formation may account for the suppression of cell migration invasion and growth of nonsmall cell lung cancer cells following treatment with polyisoprenylated cysteinyl amide inhibitors |
|
https://doi.org/10.18632/oncotarget.25372
Elizabeth Ntantie, Michaela J. Allen, Jerrine Fletcher, Augustine T. Nkembo, Nazarius S. Lamango, and Offiong F. Ikpatt
|
| 25781-25795 |
|
| Camptothecin exhibits topoisomerase1independent KMT1A suppression and myogenic differentiation in alveolar rhabdomyosarcoma cells |
|
https://doi.org/10.18632/oncotarget.25376
David W. Wolff, Min-Hyung Lee, Mathivanan Jothi, Munmun Mal, Fengzhi Li, and Asoke K. Mal
|
| 25796-25807 |
|
| Metformin exerts antitumor activity via induction of multiple death pathways in tumor cells and activation of a protective immune response |
|
https://doi.org/10.18632/oncotarget.25380
Felipe V. Pereira, Amanda Campelo L. Melo, Jun Siong Low, Ãris Arantes de Castro, Tárcio T. Braga, Danilo C. Almeida, Ana Gabriela U. Batista de Lima, Meire I. Hiyane, Matheus Correa-Costa, Vinicius Andrade-Oliveira, Clarice S.T. Origassa, Rosana M. Pereira, Susan M. Kaech, Elaine G. Rodrigues, and Niels Olsen S. Câmara
|
| 25808-25825 |
|
| Clinical validation of the Tempus xO assay |
|
https://doi.org/10.18632/oncotarget.25381
Nike Beaubier, Robert Tell, Robert Huether, Martin Bontrager, Stephen Bush, Jerod Parsons, Kaanan Shah, Tim Baker, Gene Selkov, Tim Taxter, Amber Thomas, Sam Bettis, Aly Khan, Denise Lau, Christina Lee, Matthew Barber, Marcin Cieslik, Casey Frankenberger, Amy Franzen, Ali Weiner, Gary Palmer, Robert Lonigro, Dan Robinson, Yi-Mi Wu, Xuhong Cao, Eric Lefkofsky, Arul Chinnaiyan, and Kevin P. White
|
| 25826-25832 |
|
| VX984 is a selective inhibitor of nonhomologous end joining with possible preferential activity in transformed cells |
|
https://doi.org/10.18632/oncotarget.25383
Atif J. Khan, Sarah M. Misenko, Aditya Thandoni, Devora Schiff, Sachin R. Jhawar, Samuel F. Bunting, and Bruce G. Haffty
|
| 25833-25841 |
|
| Synthetic lethality in CCNE1amplified high grade serous ovarian cancer through combined inhibition of Pololike kinase 1 and microtubule dynamics |
|
https://doi.org/10.18632/oncotarget.25386
Sabrina Noack, Monika Raab, Yves Matthess, Mourad Sanhaji, Andrea Krämer, Balázs Győrffy, Lars Kaderali, Ahmed El-Balat, Sven Becker, and Klaus Strebhardt
|
| 25842-25859 |
|
| Platelet activation parameters and plateletleucocyteconjugate formation in glioblastoma multiforme patients |
|
https://doi.org/10.18632/oncotarget.25395
Sascha Marx, Maximilian Splittstöhser, Frederik Kinnen, Eileen Moritz, Christy Joseph, Sebastian Paul, Heiko Paland, Carolin Seifert, Madlen Marx, Andreas Böhm, Edzard Schwedhelm, Kerstin Holzer, Stephan Singer, Christoph A. Ritter, Sandra Bien-Möller, Henry W.S. Schroeder, and Bernhard H. Rauch
|
| 25860-25876 |
|
| Efficient lysis of Bchronic lymphocytic leukemia cells by the plantderived sesquiterpene alcohol αbisabolol a dual proapoptotic and antiautophagic agent |
|
https://doi.org/10.18632/oncotarget.25398
Antonella Rigo, Isacco Ferrarini, Angela Bonalumi, Cristina Tecchio, Alessio Montresor, Carlo Laudanna, and Fabrizio Vinante
|
| 25877-25890 |
|
| Inhibition of Fas associated phosphatase 1 Fap1 facilitates apoptosis of colon cancer stem cells and enhances the effects of oxaliplatin |
|
https://doi.org/10.18632/oncotarget.25401
Weiqi Huang, Ling Bei, and Elizabeth A. Eklund
|
| 25891-25902 |
|
| CHL1 gene acts as a tumor suppressor in human neuroblastoma |
|
https://doi.org/10.18632/oncotarget.25403
Marzia Ognibene, Gabriella Pagnan, Danilo Marimpietri, Davide Cangelosi, Michele Cilli, Maria Chiara Benedetti, Renata Boldrini, Alberto Garaventa, Francesco Frassoni, Alessandra Eva, Luigi Varesio, Vito Pistoia, and Annalisa Pezzolo
|
| 25903-25921 |
|
| Epigenetic dysregulation of TET2 in human glioblastoma |
|
https://doi.org/10.18632/oncotarget.25406
MarÃa G. GarcÃa, Antonella Carella, RocÃo G. Urdinguio, Gustavo F. Bayón, Virginia Lopez, Juan Ramón Tejedor, Marta I. Sierra, Estela GarcÃa-Toraño, Pablo Santamarina, Raúl F. Perez, Cristina Mangas, Aurora Astudillo, M. Daniela Corte-Torres, Inés Sáenz-de-Santa-MarÃa, MarÃa-Dolores Chiara, AgustÃn F. Fernández, and Mario F. Fraga
|
| 25922-25934 |
|
| Subclassification survival prediction and drug target analyses of chemotherapynaïve muscleinvasive bladder cancer with a molecular screening |
|
https://doi.org/10.18632/oncotarget.25407
Sebastien Rinaldetti, Eugen Rempel, Thomas Stefan Worst, Markus Eckstein, Annette Steidler, Cleo Aaron Weiss, Christian Bolenz, Arndt Hartmann, and Philipp Erben
|
| 25935-25945 |
|
| Low expression of G proteincoupled oestrogen receptor 1 GPER is associated with adverse survival of breast cancer patients |
|
https://doi.org/10.18632/oncotarget.25408
Stewart G. Martin, Marie N. Lebot, Bhudsaban Sukkarn, Graham Ball, Andrew R. Green, Emad A. Rakha, Ian O. Ellis, and Sarah J. Storr
|
| 25946-25956 |
|
| Targeted DNA sequencing of nonsmall cell lung cancer identifies mutations associated with brain metastases |
|
https://doi.org/10.18632/oncotarget.25409
George D. Wilson, Matthew D. Johnson, Samreen Ahmed, Paola Yumpo Cardenas, Inga S. Grills, and Bryan J. Thibodeau
|
| 25957-25970 |
|
| Surface expression of Cytokine ReceptorLike Factor 2 increases risk of relapse in pediatric acute lymphoblastic leukemia patients harboring IKZF1 deletions |
|
https://doi.org/10.18632/oncotarget.25411
Agata Pastorczak, Lukasz Sedek, Marcin Braun, Joanna Madzio, Alicja Sonsala, Magdalena Twardoch, Wojciech Fendler, Karin Nebral, Joanna Taha, Marta Bielska, Patryk Gorniak, Magdalena Romiszewska, Michal Matysiak, Katarzyna Derwich, Monika Lejman, Jerzy Kowalczyk, Wanda Badowska, Maciej Niedzwiecki, Bernarda Kazanowska, Katarzyna Muszynska-Roslan, Grazyna Sobol-Milejska, Grazyna Karolczyk, Andrzej Koltan, Tomasz Ociepa, Tomasz Szczepanski, and Wojciech MÅ‚ynarski
|
| 25971-25982 |
|
| Activated matriptase as a target to treat breast cancer with a drug conjugate |
|
https://doi.org/10.18632/oncotarget.25414
Gulam M. Rather, Siang-Yo Lin, Hongxia Lin, Whitney Banach-Petrosky, Kim M. Hirshfield, Chen-Yong Lin, Michael D. Johnson, Zoltan Szekely, and Joseph R. Bertino
|
| 25983-25992 |
|
| Anion exchanger 2 suppresses cellular movement and has prognostic significance in esophageal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.25417
Atsushi Shiozaki, Shoichiro Hikami, Daisuke Ichikawa, Toshiyuki Kosuga, Hiroki Shimizu, Michihiro Kudou, Yuzo Yamazato, Toshiyuki Kobayashi, Katsutoshi Shoda, Tomohiro Arita, Hirotaka Konishi, Shuhei Komatsu, Takeshi Kubota, Hitoshi Fujiwara, Kazuma Okamoto, Mitsuo Kishimoto, Eiichi Konishi, Yoshinori Marunaka, and Eigo Otsuji
|
| 25993-26006 |
|
| Impact of aldosteroneproducing cell clusters on diagnostic discrepancies in primary aldosteronism |
|
https://doi.org/10.18632/oncotarget.25418
Mitsuhiro Kometani, Takashi Yoneda, Daisuke Aono, Shigehiro Karashima, Masashi Demura, Koshiro Nishimoto, Masakazu Yamagishi, and Yoshiyu Takeda
|
| 26007-26018 |
|
| A novel ex vivo highthroughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia |
|
https://doi.org/10.18632/oncotarget.25419
Daniel Primo, Lydia Scarfò, Aliki Xochelli, Mattias Mattsson, Pamela Ranghetti, Ana Belén Espinosa, Alicia Robles, Julian Gorrochategui, JoaquÃn MartÃnez-López, Javier de la Serna, Marcos González, Alberto Chaparro Gil, Eduardo Anguita, Sandra Iraheta, Veerendra Munugalavadla, Christophe Quéva, Stacey Tannheimer, Richard Rosenquist, Kostas Stamatopoulos, Joan Ballesteros, and Paolo Ghia
|
| 26019-26031 |
|
| CD44 positive and sorafenib insensitive hepatocellular carcinomas respond to the ATPcompetitive mTOR inhibitor INK128 |
|
https://doi.org/10.18632/oncotarget.25430
Mohamed Badawi, Jihye Kim, Anees Dauki, Dhruvitkumar Sutaria, Tasneem Motiwala, Ryan Reyes, Nissar Wani, Shamalatha Kolli, Jinmai Jiang, Christopher C. Coss, Samson T. Jacob, Mitch A. Phelps, and Thomas D. Schmittgen
|
| 26032-26045 |
|
| BCL2 and BCLXL selective inhibitors decrease mitochondrial ATP production in breast cancer cells and are synthetically lethal when combined with 2deoxyDglucose |
|
https://doi.org/10.18632/oncotarget.25433
Federico Lucantoni, Heiko Düssmann, Irene Llorente-Folch, and Jochen H.M. Prehn
|
| 26046-26063 |
|
| Highthroughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomaviruspositive or negative cell lines |
|
https://doi.org/10.18632/oncotarget.25436
Farhad Ghasemi, Morgan Black, Ren X. Sun, Frederick Vizeacoumar, Nicole Pinto, Kara M. Ruicci, John Yoo, Kevin Fung, Danielle MacNeil, David A. Palma, Eric Winquist, Joe S. Mymryk, Laurie A. Ailles, Alessandro Datti, John W. Barrett, Paul C. Boutros, and Anthony C. Nichols
|
| 26064-26071 |
|
| Induction of apoptosis and suppression of tumor growth by Nur77derived Bcl2 converting peptide in chemoresistant lung cancer cells |
|
https://doi.org/10.18632/oncotarget.25437
Martin C. Pearce, John T. Gamble, Prasad R. Kopparapu, Edmond F. O'Donnell, Monica J. Mueller, Hyo Sang Jang, Julie A. Greenwood, Arnold C. Satterthwait, Roberta L. Tanguay, Xiao-Kun Zhang, and Siva Kumar Kolluri
|
| 26072-26085 |
|
| Twentysevennucleotide repeat insertion in the rplV gene confers specific resistance to macrolide antibiotics in Staphylococcus aureus |
|
https://doi.org/10.18632/oncotarget.25441
Dianpeng Han, Yu Liu, Jingjing Li, Chenghua Liu, Yaping Gao, Jiannan Feng, Huizhe Lu, and Guang Yang
|
| 26086-26095 |
|
| A novel combinatorial treatment option for metastatic uveal melanoma |
|
https://doi.org/10.18632/oncotarget.25445
Dudi Shneor, Shay Tayeb, Jacob Pe'er, Hanna Voropaev, Maria Gimmelshein, Nathalie Cassoux, Alik Honigman, and Shahar Frenkel
|
| 26096-26108 |
|
| Conception synthesis and characterization of a rofecoxibcombretastatin hybrid drug with potent cyclooxygenase2 COX2 inhibiting and microtubule disrupting activities in colon cancer cell culture and xenograft models |
|
https://doi.org/10.18632/oncotarget.25450
Surendra R. Punganuru, Hanumantha Rao Madala, Constantinos M. Mikelis, Anshuman Dixit, Viswanath Arutla, and Kalkunte S. Srivenugopal
|
| 26109-26129 |
|
| Heat shock protein 90 inhibitors augment endogenous wildtype p53 expression but downregulate the adenovirallyinduced expression by inhibiting a proteasome activity |
|
https://doi.org/10.18632/oncotarget.25452
Kuan Chai, Xuerao Ning, Thảo Thi Thanh Nguyễn, Boya Zhong, Takao Morinaga, Zhihan Li, Masato Shingyoji, Yuji Tada, Koichiro Tatsumi, Hideaki Shimada, Kenzo Hiroshima, Naoto Yamaguchi, and Masatoshi Tagawa
|
| 26130-26143 |
|
| Lossoffunction mutations in Znfinger DNAbinding domain of HNF4A cause aberrant transcriptional regulation in liver cancer |
|
https://doi.org/10.18632/oncotarget.25456
Hiroaki Taniguchi, Akihiro Fujimoto, Hidetoshi Kono, Mayuko Furuta, Masashi Fujita, and Hidewaki Nakagawa
|
| 26144-26156 |
|
| Lymph microvascularization as a prognostic indicator in neuroblastoma |
|
https://doi.org/10.18632/oncotarget.25457
Irene Tadeo, Esther Gamero-Sandemetrio, Ana P. Berbegall, Marta Gironella, Félix Ritort, Adela Cañete, Gloria Bueno, Samuel Navarro, and Rosa Noguera
|
| 26157-26170 |
|
| Translation terminationdependent deadenylation of MYC mRNA in human cells |
|
https://doi.org/10.18632/oncotarget.25459
Béatrice Jolles, Affaf Aliouat, Vérène Stierlé, Samia Salhi, and Olivier Jean-Jean
|
| 26171-26182 |
|
| Association of mRNA expression of iron metabolismassociated genes and progression of nonalcoholic steatohepatitis in rats |
|
https://doi.org/10.18632/oncotarget.25488
Teruhisa Higuchi, Mitsuhiko Moriyama, Akiko Fukushima, Hiroshi Matsumura, Shunichi Matsuoka, Tatsuo Kanda, Masahiko Sugitani, Akiko Tsunemi, Takahiro Ueno, and Noboru Fukuda
|
| 26183-26194 |
|
| Concomitant driver mutations in advanced EGFRmutated nonsmallcell lung cancer and their impact on erlotinib treatment |
|
https://doi.org/10.18632/oncotarget.25490
Jan Nyrop Jakobsen, Eric Santoni-Rugiu, Morten Grauslund, Linea Melchior, and Jens Benn Sørensen
|
| 26195-26208 |
|
| Diffusionweighted MRI in the evaluation of the thyroid nodule: Comparison between integratedshimming EPI and conventional 3Dshimming EPI techniques |
|
https://doi.org/10.18632/oncotarget.25279
Luguang Chen, Peipei Sun, Qiang Hao, Wei Yin, Bing Xu, Chao Ma, Alto Stemmer, Caixia Fu, Minjie Wang, and Jianping Lu
|
| 26209-26216 |
|
| The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians |
|
https://doi.org/10.18632/oncotarget.25439
Katharina C. Kähler, Christine Blome, Andrea Forschner, Ralf Gutzmer, Axel Hauschild, Lucie Heinzerling, Elisabeth Livingstone, Carmen Loquai, Tina Müller-Brenne, Dirk Schadendorf, Jochen Utikal, Tobias Wagner, and Matthias Augustin
|
| 26217-26225 |
|
| Modeling small cell lung cancer SCLC biology through deterministic and stochastic mathematical models |
|
https://doi.org/10.18632/oncotarget.25360
Ravi Salgia, Isa Mambetsariev, Blake Hewelt, Srisairam Achuthan, Haiqing Li, Valeriy Poroyko, Yingyu Wang, and Martin Sattler
|
| 26226-26242 |
|
| Targeting the SET and RINGassociated SRA domain of ubiquitinlike PHD and ring finger–containing 1 UHRF1 for anticancer drug development |
|
https://doi.org/10.18632/oncotarget.25425
Debasis Patnaik, Pierre-Olivier Estève, and Sriharsa Pradhan
|
| 26243-26258 |
|
| Role of p27Kip1 as a transcriptional regulator |
|
https://doi.org/10.18632/oncotarget.25447
Oriol Bachs, Edurne Gallastegui, Serena Orlando, Anna Bigas, José Manuel Morante-Redolat, Joan Serratosa, Isabel Fariñas, Rosa Aligué, and Maria Jesús Pujol
|
| 26259-26278 |
